HIV患者中动脉粥样硬化性心血管疾病（ASCVD）风险的演变情况
The Evolving Landscape of ASCVD Risk Among Patients With HIV.
作者信息
Malvestutto Carlos
机构信息
Carlos Malvestutto, MD, MPH, Associate Professor of Medicine, Division of Infectious Diseases, The Ohio State University Wexler Medical Center, Columbus, Ohio.
出版信息
J Fam Pract. 2022 Jul;71(6 Suppl):S58-S62. doi: 10.12788/jfp.0412.
Summarize the multiple atherosclerotic cardiovascular disease (ASCVD) risk factors commonly present in persons living with human immunodeficiency virus (HIV). Identify factors for clinical assessment and risk stratification in persons with HIV (PWH). Discuss the clinical challenges of dyslipidemia management among the HIV population, including avoidance of major drug-drug interactions (DDIs). Implement appropriate and safe statin therapy in PWH and elevated ASCVD risk.
总结人类免疫缺陷病毒（HIV）感染者中常见的多种动脉粥样硬化性心血管疾病（ASCVD）危险因素。确定HIV感染者（PWH）临床评估和风险分层的因素。讨论HIV人群血脂异常管理的临床挑战，包括避免重大药物相互作用（DDIs）。对ASCVD风险升高的PWH实施适当且安全的他汀类药物治疗。
Zotero 插件